Chronic obstructive pulmonary disease (COPD) remains significantly underdiagnosed in the Philippines despite being the country's seventh leading cause of death, limiting opportunities for early treatment among millions of at-risk Filipinos.
AstraZeneca Philippines and De La Salle University (DLSU) have signed a memorandum of understanding to strengthen collaboration in healthcare innovation, research, and talent development through the university’s PEZA-accredited innovation district.
Healthway Cancer Care Hospital (HCCH), the country’s first specialty hospital dedicated to cancer care, has partnered with AstraZeneca to open its Lung Center of Excellence (COE) and Lung Nodule Clinic, aiming to improve lung cancer detection, treatment, and survivorship in the Philippines.
The Philippines is cementing its lead as Southeast Asia’s largest pharmaceutical market, with fresh global investments poised to accelerate industry growth.